Rani Therapeutics Holdings, Inc. (RANI)
0.8527
+0.01
(+1.51%)
USD |
NASDAQ |
Aug 31, 11:27
Rani Therapeutics Holdings Price to Book Value : 2.445 for Aug. 31, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.409 |
| August 27, 2026 | 2.449 |
| August 26, 2026 | 2.413 |
| August 25, 2026 | 2.555 |
| August 24, 2026 | 2.520 |
| August 21, 2026 | 2.523 |
| August 20, 2026 | 2.440 |
| August 19, 2026 | 2.628 |
| August 18, 2026 | 2.367 |
| August 17, 2026 | 2.282 |
| August 14, 2026 | 2.283 |
| August 13, 2026 | 2.288 |
| August 12, 2026 | 2.302 |
| August 11, 2026 | 2.251 |
| August 10, 2026 | 2.228 |
| August 07, 2026 | 2.271 |
| August 06, 2026 | 2.240 |
| August 05, 2026 | 2.237 |
| August 04, 2026 | 2.351 |
| August 03, 2026 | 2.298 |
| July 31, 2026 | 2.220 |
| July 30, 2026 | 2.352 |
| July 29, 2026 | 2.420 |
| July 28, 2026 | 2.349 |
| July 27, 2026 | 2.323 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.440 |
| July 23, 2026 | 2.552 |
| July 22, 2026 | 2.571 |
| July 21, 2026 | 1.981 |
| July 20, 2026 | 1.968 |
| July 17, 2026 | 1.999 |
| July 16, 2026 | 1.921 |
| July 15, 2026 | 1.941 |
| July 14, 2026 | 1.861 |
| July 13, 2026 | 1.814 |
| July 10, 2026 | 1.970 |
| July 09, 2026 | 2.002 |
| July 08, 2026 | 1.987 |
| July 07, 2026 | 2.034 |
| July 06, 2026 | 2.274 |
| July 02, 2026 | 2.212 |
| July 01, 2026 | 2.203 |
| June 30, 2026 | 2.180 |
| June 29, 2026 | 2.687 |
| June 26, 2026 | 2.586 |
| June 25, 2026 | 2.608 |
| June 24, 2026 | 2.695 |
| June 23, 2026 | 2.653 |
| June 22, 2026 | 2.715 |
| June 18, 2026 | 2.749 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.53 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 1.051 |
| Fulcrum Therapeutics, Inc. | 0.9404 |
Price to Book Value Related Metrics
| PS Ratio | 24.51 |
| Price | 0.8527 |
| Earnings Yield | -31.10% |
| Market Cap | 95.93M |